-

IFF Announces Executive Leadership Team Aligned With New Operating Model

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) announced changes to its executive leadership team, aligned with the Company’s external reporting structure.

After 21 years of dedicated service to IFF, Simon Herriott, president of Health and Biosciences, will step down. Effective March 1, Leticia Gonçalves, ADM’s president of precision fermentation and ADM Ventures, will join IFF as president of Health and Biosciences.

“Since 2019, Simon has driven growth and operational effectiveness through innovation, customer intimacy and supply chain development as president of our Health and Biosciences business unit,” said Erik Fyrwald, IFF CEO. “We’re grateful for Simon’s tremendous contributions to IFF and wish him well for the future. His dedication and leadership will leave a lasting impact on our organization.”

Gonçalves brings to IFF extensive experience with IFF’s end markets in innovation-based companies, having served in various senior global and regional P&L leadership roles at ADM, Bayer and Monsanto in Brazil, Europe and the United States. She was most recently president of precision fermentation and ventures at ADM, where she developed new businesses to serve growing customer needs across various food, health and wellness, agriculture and industrial applications. She also led ADM’s Specialty Ingredients and Foods businesses driving innovation, culture and productivity to maximize value creation across food security, supply chain resilience and sustainability. She is a board member of Emerson Electric.

“We’re excited to welcome Leticia to IFF,” said Fyrwald. “Her extensive experience driving P&L growth in innovation-led businesses and accelerating high-performing teams—coupled with her knowledge of our end markets—will be a great addition to our leadership team. I’m confident Leticia will continue to build on our cutting-edge biotechnology platform of probiotics, cultures and enzymes and drive our next phase of business growth.”

Also new to the executive leadership team, Andy Muller serves as IFF’s president of Food Ingredients. He joined IFF in December 2024 with a wealth of experience in food ingredients. Most recently, he served as president of Functional Ingredients and Solutions at Corbion where he focused on bakery, meat, dairy, confectionery, beverage industries, pet food and biochemicals. He spent 12 years with Danisco, later DuPont’s Nutrition and Health business, where he grew the business by expanding organizational capabilities, rationalizing the product portfolio, and refocusing efforts on core end-market applications. He serves on the board of PureField Ingredients.

“Andy’s deep experience in food ingredients and knowledge of our business will support our focus to deliver growth in our specialty ingredients business and increased value to our customers. We’re excited to have him on board as we continue to grow and innovate.”

Yuvraj Arora, previously President, Nourish, has assumed the role of President, Taste and Chief Commercial Officer. Ana Paula Mendonça, President, Scent, and Angela Strzelecki, President, Pharma Solutions, maintain their current divisional leadership roles.

IFF’s executive leadership team now includes:

  • Erik Fyrwald, CEO
  • Michael DeVeau, EVP, Chief Financial Officer
  • Yuvraj Arora, President, Taste and Chief Commercial Officer
  • Ana Paula Mendonça, President, Scent
  • Leticia Gonçalves, President, Health & Biosciences
  • Andy Muller, President, Food Ingredients
  • Angela Strzelecki, President, Pharma Solutions
  • Deborah Borg, EVP, Chief People & Culture Officer
  • Ralph Finzel, EVP, Global Operations Officer
  • Vic Verma, EVP, Chief Information Officer
  • Jennifer Johnson, EVP, General Counsel and Corporate Secretary
  • Steve Landsman, EVP, Business Development

Welcome to IFF
At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products—advancing wellness, delighting the senses and enhancing the human experience. Learn more at iff.com, LinkedIn, Instagram and Facebook.

© 2025 by International Flavors & Fragrances Inc. IFF is a Registered Trademark. All Rights Reserved.

Contacts

Media Relations:
Paulina Heinkel
332.877.5339
Media.request@iff.com

Investor Relations:
Michael Bender
212.708.7263
Investor.Relations@iff.com

IFF

NYSE:IFF

Release Versions

Contacts

Media Relations:
Paulina Heinkel
332.877.5339
Media.request@iff.com

Investor Relations:
Michael Bender
212.708.7263
Investor.Relations@iff.com

More News From IFF

IFF Report Finds GLP-1 Is Reshaping Food Choices and Eating Behaviors Among Indian Consumers

NEW DELHI--(BUSINESS WIRE)--IFF (NYSE: IFF) — a global leader in flavors, fragrances and health and biosciences — released new research examining how GLP-1 use is influencing food behaviors among Indian consumers and what those shifts may mean for the future of food and beverage innovation. The study is the latest in IFF’s GLP-1 global consumer insights following the company’s 2025 GLP-1 Consumer Opportunity Outlook. “We are seeing that a change in appetite can lead to a broader change in the r...

IFF to Webcast Fireside Chat at Barclays Global Consumer Conference on Sept. 10

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) today announced that Chief Executive Officer Erik Fyrwald will participate in a fireside chat at the Barclays Global Consumer Conference on Thursday, Sept. 10, 2026 at 945 a.m. ET. Investors may access the live webcast on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available for replay. Welcome to IFF At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the gl...

IFF Reports Second Quarter 2026 Results; Announces Use of Proceeds Plan for Food Ingredients Divestiture

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) reported financial results for the second quarter ended June 30, 2026. Results are presented on a continuing operations basis, excluding the Food Ingredients business and other minor perimeter adjustments (the “Food Ingredients disposal group”), and the Soy Crush, Concentrates, and Lecithin businesses (the “SCL disposal group”). The Food Ingredients disposal group and the SCL disposal group are reported as discontinued operations. Second Quarter 2026 C...
Back to Newsroom